← FDA Drug Approvals (Drugs@FDA)
BENDAMUSTINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2023-06-05
Drug application
- FDA Application #
ANDA204230- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BENDAMUSTINE HYDROCHLORIDE
- Generic name
- Bendamustine Hydrochloride
- Active ingredients
- BENDAMUSTINE HYDROCHLORIDE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2023-06-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown